Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan

Mansoor, M., De Glanville, W. A., Alam, R., Aslam, K., Ahmed, M., Isaakidis, P. and Pasha, A. (2023) Prevalence and risk factors for hepatitis C virus infection in an informal settlement in Karachi, Pakistan. PLoS Global Public Health, 3(9), e0002076. (doi: 10.1371/journal.pgph.0002076) (PMID:37729129) (PMCID:PMC10511086)

[img] Text
308156.pdf - Published Version
Available under License Creative Commons Attribution.

1MB

Abstract

The burden of hepatitis C virus (HCV) infection in Pakistan is amongst the highest in the world. People living in slums are likely to be at high risk of infection. Here, we describe the results of a cross-sectional survey conducted in March 2022 that aimed to quantify the prevalence of HCV infection in Machar Colony, one of the largest and oldest slum settlements in Karachi. Risk factors for HCV seropositivity were identified using multi-level logistic regression. We recruited 1,303 individuals in a random selection of 441 households from Machar Colony. The survey-adjusted HCV-seroprevalence was 13.5% (95% Confidence Interval (CI) 11.1–15.8) and survey-adjusted viraemic prevalence was 4.1% (95% CI 3.1–5.4) with a viraemic ratio of 32% (95% CI 24.3–40.5). Of 162 seropositive people, 71 (44%) reported receiving previous treatment for chronic hepatitis C. The odds of HCV seropositivity were found to increase with each additional reported therapeutic injection in the past 12 months (OR = 1.07 (95% Credible Interval (CrI) 1.00–1.13)). We found weaker evidence for a positive association between HCV seropositivity and a reported history of receiving a blood transfusion (OR = 1.72 (95% CrI 0.90–3.21)). The seroprevalence was more than double the previously reported seroprevalence in Sindh Province. The overall proportion of seropositive people that were viraemic was lower than expected. This may reflect the long-term impacts of a non-governmental clinic providing free of cost and easily accessible hepatitis C diagnosis and treatment to the population since 2015. Reuse of needles and syringes is likely to be an important driver of HCV transmission in this setting. Future public health interventions should address the expected risks associated with iatrogenic HCV transmission in this community.

Item Type:Articles
Additional Information:This Project was funded by Foundation for Innovative New Diagnostics.
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:De Glanville, Dr William
Authors: Mansoor, M., De Glanville, W. A., Alam, R., Aslam, K., Ahmed, M., Isaakidis, P., and Pasha, A.
College/School:College of Medical Veterinary and Life Sciences > School of Biodiversity, One Health & Veterinary Medicine
Journal Name:PLoS Global Public Health
Publisher:Public Library of Science
ISSN:2767-3375
ISSN (Online):2767-3375
Copyright Holders:Copyright © 2023 The Authors
First Published:First published in PLoS Global Public Health 3(9):e0002076
Publisher Policy:Reproduced under a Creative Commons License

University Staff: Request a correction | Enlighten Editors: Update this record